ASTS Response to the CMS RFI on Health and Safety Requirements for Transplant Centers, February 1, 2022 (pdf)

Powers Memo on No Surprises Act Implementation and Litigation, January 12, 2022 (pdf)

ASTS Comments to FDA on PHS Guidelines on Infectious Disease in Xenotransplantation, December 20, 2021 (pdf)

Joint UNOS-AST-ASTS Letter to FDA on Organ Preservation Solution Shortage, December 16, 2021 (pdf)

Powers Memo on Final 2022 PFS Rate for Transplantation, November 4, 2021 (pdf)

Congressional Sign On Letter to US House Leaders on Medicare Physician Payment Cuts, October 14, 2021 (pdf)

ASTS Signs on to S-FAR Letter to the White House Prioritizing AMR for Pandemic Preparedness, October 12, 2021 (pdf)

ASTS Presentation to SRTR Task5 Steering Committee, September 23, 2021 (pdf)

ASTS Comments on the FY2022 ESRD Treatment Choices Model Proposed Rule August 23 2021 (pdf)

Powers Memo on 2022 PFS Rate for Transplantation, July 19, 2021 (pdf)

ASTS Statement to NASEM, July 15, 2021 (pdf)

ASTS Signs Coalition Letter on the PFS Proposed Rule, July 23, 2021 (pdf)

U.S. House Members Sign On Letter to CMS Administrator Brooks-LaSure on the IPPPS Proposed Rule, July 16, 2021 (1) (pdf)

ASTS Stakeholder and Allies Sign on Letter regarding the FY 2022 IPPS Proposed Rule, June 28, 2021 (pdf)

ASTS Comments on FY2022 IPPS Proposed Rule_2021.6.25 (pdf)

ASTS Comments on VA Proposed Rule on Transplant Procedures with Live Donors and Related Care and Services, May 7, 2021 (pdf)

ASTS Comments on HHS AHRQ RFI on Clinical Algorithms and Race-Ethnic Bias, April 28, 2021 (pdf)

AST-ASTS-UNOS Joint Comment on CMS OPO CfCs Final Rule, March 2021 (pdf)

ASTS Comments on OPO Conditions for Coverage Final Rule, March 1, 2021 (pdf)

ASTS Signs on to S-FAR Letter to Prioritize AMR at the G7, February 23, 2021 (pdf)